| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $476.5M | +16.7% |
| Cost of Revenue | $191.5M | +12.9% |
| Gross Profit | $285.1M | +19.4% |
| R&D Expense | $117.3M | -3.5% |
| SG&A Expense | $76.7M | -8.1% |
| Operating Income | -$39.5M | +58.0% |
| Interest Expense | $4.1M | +47.3% |
| Pre-tax Income | -$41.9M | +57.1% |
| Income Tax | $1.6M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $112.1M | +36.6% |
| Accounts Receivable | $113.0M | +13.5% |
| Current Assets | $250.8M | +21.0% |
| Total Assets | $1.34B | +1.0% |
| Current Liabilities | $215.0M | +4.8% |
| Total Liabilities | $287.8M | -3.9% |
| Stockholders' Equity | $1.05B | +2.5% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $57.3M | +472.4% |
| Capital Expenditures | $3.5M | -80.8% |
| Investing Cash Flow | -$6.3M | +69.5% |
| Financing Cash Flow | -$21.1M | -157.5% |
| Free Cash Flow | $53.8M | +259.5% |
| -60.9% |
| Net Income | -$42.3M | +58.8% |
| EPS (Basic) | -$0.38 | +59.1% |
| EPS (Diluted) | -$0.38 | +59.1% |